STRO Sutro Biopharma, Inc. - Common Stock
$22.16
株価 · 8月 18, 2026
ファンダメンタルズ（時点） 8月 12, 2026
52週レンジ
$1–$44
50% of range
アナリスト評価
BUY
19 analysts
目標株価
$48
+116% upside
P/E (TTM)
-1.0
ROE
232.2%
純利益率
-186.5%
Sutro Biopharma, Inc. - Common Stock について Wikipediaからの企業概要
Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in January 2009.
続きを読む
Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in January 2009.
Sutro's cell-free protein synthesis and site-specific conjugation platform, XpressCF+, contributed to the discovery of STRO-001 and STRO-002, internally-developed antibody drug conjugates, or ADCs. STRO-001 is an ADC targeting CD74, a protein highly expressed in multiple myeloma and non-Hodgkin's lymphoma, and is currently in a Phase I clinical trial. STRO-002 is an ADC targeting folate receptor alpha, a cell-surface protein highly expressed in gynecological cancers.
As of 2024 Sutro's drug discovery efforts have focused on antibody-drug conjugates, cytokine-based immuno-oncology therapies, and bispecific antibodies primarily directed at clinically validated targets for which the current standard of care is suboptimal.
Technology
Sutro's Xpress CF Platform is based on Stanford Professor James R. Swartz's patented Open Cell-Free Synthesis (OCFS) technology. XpressCF technology enables the parallel expression of hundreds of protein variants in less than 24 hours, providing a platform for the discovery and development of a wide variety of protein classes including cytokines, vaccine carrier-proteins, antibodies, and novel antibody-based proteins. The XpressCF+ platform allows for precise incorporation of non-natural amino acids into a protein sequence, and Sutro is using this technology to develop homogeneous site-specific antibody-drug conjugates (ADCs). Once identified, production of protein drug candidates can be scaled in Sutro's cGMP manufacturing facility located in San Carlos, CA.
Sutro's technology has also contributed to the formation of SutroVax, a vaccine spin off founded in 2015 that has raised over US$170 million in capital.
Collaborations
In July 2018, Sutro signed a collaboration and licensing agreement with Merck to discover and develop novel cytokine-based therapies for cancer and autoimmune disorders. Sutro received an upfront payment of $60 million and is eligible for milestone payments totaling up to $1.6 billion associated with the development and sale of all therapeutic candidates and all possible indications identified under the collaboration. In 2017, Sutro and Celgene announced they had refocused their 2014 immuno-oncology collaboration on four programs advancing through preclinical development, including an ADC program targeting B-Cell maturation antigen (BCMA).
Awards
The XpressCF Platform was awarded Best ADC Technology Platform at the World ADC in 2018, with Sutro as the runner up for Best New Drug Developer. Sutro was named one of Fierce Biotech's Fierce 15 in 2014. In 2015 was awarded the DiNA Outstanding Partner Award by the California Life Sciences Association.
== References ==
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
STRO 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$22.16
時価総額
$190M
P/E (TTM)
-1.0
EPS（TTM）
$-22.49
収益（TTM）
$102M
配当利回り
—
ROE
232.2%
負債/自己資本
—
52週レンジ
$1 – $44
STRO 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
Configure
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益と純利益
$102M
2016-12-31
→
2025-12-31
EPS
$-22.49
2020-12-31
→
2025-12-31
フリーキャッシュフロー
—
2018-12-31
→
2018-12-31
利益率
-186.5%
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
指標
5年トレンド
STRO
競合中央値
P/E (TTM)
-1.0
6.1
P/S (TTM) (株価売上高倍率（TTM）)
1.9
7.7
P/B (株価純資産倍率)
-1.4
2.2
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
指標
5年トレンド
STRO
競合中央値
Operating Margin (営業利益率)
-154.5%
—
Net Profit Margin (純利益率)
-186.5%
-60.9%
ROA
-68.1%
-50.0%
ROE
232.2%
-44.8%
ROIC
119.5%
—
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
指標
5年トレンド
STRO
競合中央値
Current Ratio (流動比率)
2.0
5.9
Quick Ratio (クイックレシオ)
1.9
—
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
指標
5年トレンド
STRO
競合中央値
Revenue YoY (収益（前年比）)
65.2%
—
Revenue CAGR 3Y (収益（3年CAGR）)
14.8%
—
Revenue CAGR 5Y (収益（5年CAGR）)
19.1%
—
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
指標
5年トレンド
STRO
競合中央値
STRO アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
買い
19 アナリスト
- 強い買い 5 26.3%
- 買い 12 63.2%
- 保有 1 5.3%
- 売り 1 5.3%
- 強い売り 0 0.0%
12ヶ月目標株価
13 アナリスト · 2026-08-13
中央値
$50.00
現在
$22.16
安値
$10.00
高値
$61.00
中央値ターゲット
$50.00
+125.6%
平均値ターゲット
$47.77
+115.6%
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
-0.34%
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年3月31日 | $-2.94 | $-3.85 | 0.91% |
| 2025年12月31日 | $-5.29 | $-4.43 | -0.86% |
| 2025年9月30日 | $-6.70 | $-4.23 | -2.5% |
| 2025年6月30日 | $-1.40 | $-4.10 | 2.7% |
| 2025年3月31日 | $-9.10 | $-7.22 | -1.9% |
| 2024年12月31日 | $-8.90 | $-8.48 | -0.42% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | — |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | — |
| DMAC | $428M | — | — | — | -78.7% | — |
| GALT | $271M | -8.7 | — | — | 25.0% | — |
| ZNTL | $93M | -0.7 | — | — | -49.5% | — |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | — |
| SABS | — | — | — | — | — | — |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | — |
| IMRX | — | -5.2 | — | — | -45.3% | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 15
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $102M | $62M | $154M | $68M | $62M | $43M | $43M | $38M | $52M | |
| R&D Expense | $166M | $252M | $180M | $137M | $104M | $77M | $66M | $54M | $55M | |
| SG&A Expense | $41M | $48M | $63M | $60M | $56M | $37M | $33M | $21M | $16M | |
| Operating Expenses | $261M | $300M | $243M | $197M | $160M | $114M | $98M | $76M | $71M | |
| Operating Income | $-158M | $-238M | $-89M | $-129M | $-99M | $-71M | $-55M | $-37M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | $2M | $612.0K | |
| Other Non-op | · | · | · | · | · | · | · | $2M | $-77.0K | |
| Pretax Income | $-191M | $-225M | $-89M | $-117M | $-106M | $-32M | · | · | · | |
| Income Tax | $-93.0K | $2M | $18M | $2M | $0 | $103.0K | $0 | $0 | $0 | |
| Net Income | $-191M | $-227M | $-107M | $-119M | $-106M | $-32M | $-119M | $-35M | $-20M | |
| EPS (Basic) | $-22.49 | $-29.40 | $-1.78 | $-2.35 | $-2.29 | $-0.99 | · | · | · | |
| EPS (Diluted) | $-22.49 | $-29.40 | $-1.78 | $-2.35 | $-2.29 | $-0.99 | · | · | · | |
| Shares (Basic) | 8,497,798 | 7,736,734 | 60,163,542 | 50,739,185 | 46,119,089 | 32,573,469 | · | · | · | |
| Shares (Diluted) | 8,497,798 | 7,736,734 | 60,163,542 | 50,739,185 | 46,119,089 | 32,573,469 | · | · | · | |
| EBITDA | $-151M | $-231M | $-82M | $-123M | $-94M | $-67M | · | $-33M | · |
貸借対照表 24
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $190M | $69M | $47M | $30M | $206M | $5M | $125M | $22M | |
| Short-term Investments | $83M | $127M | $264M | $255M | $130M | $120M | $113M | $79M | · | |
| Receivables | $4M | $9M | $36M | $7M | $12M | $6M | $6M | $2M | $2M | |
| Prepaid Expense | $6M | $18M | $10M | $12M | $8M | $4M | $4M | $3M | $2M | |
| Current Assets | $151M | $343M | $422M | $353M | $219M | $378M | $129M | $210M | $26M | |
| PP&E (Net) | $11M | $18M | $22M | $25M | $23M | $13M | $10M | $11M | $14M | |
| PP&E (Gross) | $38M | $67M | $64M | $63M | $56M | $50M | $43M | $40M | $39M | |
| Accum. Depreciation | $27M | $49M | $42M | $38M | $33M | $37M | $34M | $29M | $25M | |
| Other Non-current Assets | $495.0K | $7M | $4M | $2M | $2M | $2M | $3M | $2M | $1M | |
| Total Assets | $174M | $387M | $471M | $407M | $341M | $394M | $156M | $223M | $41M | |
| Accounts Payable | $8M | $10M | $9M | $5M | $6M | $6M | $6M | $3M | $3M | |
| Accrued Liabilities | $15M | $13M | $15M | $13M | $11M | $9M | $6M | $6M | $4M | |
| Current Liabilities | $75M | $132M | $94M | $67M | $42M | $30M | $33M | $36M | $32M | |
| Capital Leases | $8M | $16M | $23M | $30M | $31M | · | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $119.0K | $146.0K | $481.0K | $134.0K | $102.0K | $14.0K | |
| Total Liabilities | $306M | $343M | $321M | $190M | $89M | $62M | $59M | $92M | $47M | |
| Long-term Debt | · | · | $4M | $16M | $25M | $25M | · | $15M | · | |
| Total Debt | · | · | $4M | $16M | $25M | $25M | · | $10M | · | |
| Common Stock | $9.0K | $8.0K | $61.0K | $58.0K | $46.0K | $46.0K | $23.0K | $23.0K | · | |
| Retained Earnings | $-978M | $-787M | $-559M | $-453M | $-333M | $-228M | $-196M | $-150M | $-115M | |
| AOCI | $19.0K | $39.0K | $21.0K | $-618.0K | $-314.0K | $129.0K | $165.0K | $-47.0K | · | |
| Stockholders' Equity | $-132M | $45M | $150M | $217M | $253M | $332M | $98M | $132M | $-109M | |
| Liabilities + Equity | $174M | $387M | $471M | $407M | $341M | $394M | $156M | $223M | $41M | |
| Shares Outstanding | 8,584,309 | 8,306,398 | 61,009,829 | 57,499,541 | 46,327,131 | 45,752,116 | 23,098,969 | 22,848,184 | 465,330 |
キャッシュフロー 16
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $7M | $7M | $6M | $5M | $4M | $5M | $5M | $5M | |
| Stock-based Comp | $14M | $25M | $25M | $26M | $23M | $12M | $10M | $3M | $1M | |
| Restructuring | $13M | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-7M | $4M | $-37M | $91M | $-4M | $-52M | · | $41M | · | |
| Operating Cash Flow | $-177M | $-192M | $-112M | $4M | $-82M | $-68M | $-65M | $13M | $-37M | |
| CapEx | · | · | · | · | · | · | · | $2M | $3M | |
| Investing Cash Flow | $45M | $219M | $-4M | $-35M | $-97M | $604.0K | $-51M | $-80M | $33M | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $15M | |
| Net Debt Issued | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | $0 | $25M | $0 | $0 | · | $251M | $-327.0K | · | · | |
| Stock Repurchased | · | · | · | · | $7.0K | · | · | · | · | |
| Net Stock Activity | $0 | $25M | $12M | $56M | $-7.0K | $251M | · | · | · | |
| Financing Cash Flow | $44.0K | $94M | $138M | $48M | $3M | $269M | $-4M | $171M | $15M | |
| Net Change in Cash | $-132M | $121M | $22M | $17M | $-176M | $202M | $-120M | $103M | $10M | |
| Taxes Paid | $75.0K | $18M | $379.0K | $0 | $103.0K | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | $11M | · |
収益性 7
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -154.5% | -384.3% | -58.1% | -190.3% | -159.2% | -166.3% | · | -96.9% | · | |
| Net Margin | -186.5% | -366.6% | -69.5% | -175.9% | -170.6% | -75.2% | · | -91.9% | · | |
| Pretax Margin | -186.5% | -362.8% | -57.6% | -172.2% | · | · | · | · | · | |
| EBITDA Margin | -147.4% | -372.7% | -53.6% | -181.9% | -151.4% | -156.3% | · | -85.1% | · | |
| ROA | -68.1% | -53.0% | -24.3% | -31.9% | -28.7% | -11.7% | · | -26.8% | · | |
| ROE | 232.2% | -292.0% | -81.5% | -53.4% | -39.4% | -11.2% | · | 713.8% | · | |
| ROIC | 119.5% | -540.2% | -70.0% | -56.5% | · | · | · | · | · |
流動性と支払能力 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.6 | 4.5 | 5.3 | 5.2 | 12.8 | · | 5.8 | · | |
| Quick Ratio | 1.9 | 2.5 | 3.9 | 4.7 | 4.2 | 11.2 | · | 5.7 | · | |
| Debt / Equity | · | · | 0.0 | 0.1 | 0.1 | 0.1 | · | 0.1 | · | |
| LT Debt / Equity | · | · | 0.0 | 0.0 | 0.1 | 0.1 | · | 0.1 | · | |
| Interest Coverage | · | · | · | · | · | · | · | -22.9 | · |
効率性 2
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.1 | 0.4 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | |
| Receivables Turnover | 16.3 | 2.8 | 7.1 | 6.9 | 6.9 | 7.2 | · | 18.7 | · |
成長率 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 65.2% | -59.6% | 126.8% | 9.5% | 44.8% | · | · | · | · | |
| Revenue CAGR 3Y | 14.8% | 0.09% | 53.2% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.1% | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 14
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $102M | $62M | $154M | $68M | $62M | $43M | $43M | $38M | · | |
| Net Income TTM | $-191M | $-227M | $-107M | $-119M | $-106M | $-32M | $-119M | $-35M | · | |
| Market Cap | $99M | $152M | $262M | $465M | $689M | $993M | · | $206M | · | |
| Enterprise Value | · | · | $-68M | $179M | $554M | $691M | · | $12M | · | |
| P/E | -0.5 | -0.1 | -2.4 | -3.4 | -6.5 | -21.9 | · | · | · | |
| P/S | 1.0 | 2.4 | 1.7 | 6.9 | 11.1 | 23.2 | · | 5.4 | · | |
| P/B | -0.7 | 3.4 | 1.7 | 2.1 | 2.7 | 3.0 | · | 1.6 | · | |
| P / Tangible Book | · | 3.4 | 1.7 | 2.1 | 2.7 | 3.0 | · | · | · | |
| P / Cash Flow | -0.6 | -0.8 | -2.3 | 130.9 | -8.4 | -14.6 | · | 16.2 | · | |
| P / FCF | · | · | · | · | · | · | · | 18.5 | · | |
| EV / EBITDA | · | · | 0.8 | -1.4 | -5.9 | -10.4 | · | -0.4 | · | |
| EV / FCF | · | · | · | · | · | · | · | 1.0 | · | |
| EV / Revenue | · | · | -0.4 | 2.6 | 8.9 | 16.2 | · | 0.3 | · | |
| Earnings Yield | -194.4% | -1597.8% | -41.5% | -29.1% | -15.4% | -4.6% | · | · | · |
損益計算書 13
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $15M | $12M | $10M | $64M | $17M | $15M | $9M | $26M | $13M | $114M | $17M | $10M | $13M | $9M | $25M | |
| R&D Expense | $32M | $37M | $37M | $40M | $38M | $52M | $71M | $62M | $62M | $57M | $54M | $46M | $42M | $39M | $43M | $32M | |
| SG&A Expense | $8M | $8M | $9M | $9M | $10M | $13M | $9M | $14M | $12M | $13M | $17M | $15M | $15M | $16M | $15M | $15M | |
| Operating Expenses | $40M | $44M | $50M | $58M | $67M | $86M | $80M | $76M | $74M | $70M | $71M | $61M | $57M | $55M | $58M | $46M | |
| Operating Income | $-30M | $-30M | $-38M | $-48M | $-3M | $-69M | $-65M | $-68M | $-49M | $-57M | $43M | $-44M | $-46M | $-42M | $-49M | $-21M | |
| Pretax Income | $-39M | $-38M | $-47M | $-57M | $-12M | $-76M | $-70M | $-49M | $-48M | $-58M | $47M | $-47M | $-38M | $-50M | $-35M | $-19M | |
| Income Tax | $1.0K | $-15.0K | $-82.0K | $0 | $-18.0K | $7.0K | $2M | $0 | $8.0K | · | $16M | $2M | $151.0K | $395.0K | $0 | $0 | |
| Net Income | $-39M | $-38M | $-47M | $-57M | $-11M | $-76M | $-72M | $-49M | $-48M | $-58M | $31M | $-49M | $-39M | $-50M | $-35M | $-19M | |
| EPS (Basic) | $-2.33 | $-2.94 | $-20.77 | $-0.67 | $-1.35 | $-9.08 | $-27.63 | $-0.59 | $-0.59 | $-0.59 | $0.52 | $-0.81 | $-0.64 | $-0.85 | $-0.59 | $-0.37 | |
| EPS (Diluted) | $-2.33 | $-2.94 | $-20.77 | $-0.67 | $-1.35 | $-9.08 | $-27.63 | $-0.59 | $-0.59 | $-0.59 | $0.52 | $-0.81 | $-0.64 | $-0.85 | $-0.59 | $-0.37 | |
| Shares (Basic) | 16,571,602 | 13,082,355 | -244,058,204 | 84,869,864 | 8,511,985 | 8,364,294 | -216,989,358 | 82,043,671 | 81,224,628 | 61,457,793 | -119,498,390 | 60,599,025 | 60,339,475 | 58,723,432 | -95,063,345 | 52,345,732 | |
| Shares (Diluted) | 16,571,602 | 13,082,355 | -244,058,204 | 84,869,864 | 8,511,985 | 8,364,294 | -216,989,358 | 82,043,671 | 81,224,628 | 61,457,793 | -119,498,390 | 60,599,025 | 60,339,475 | 58,723,432 | -95,063,345 | 52,345,732 | |
| EBITDA | $-30M | $-28M | · | $-48M | $-3M | $-67M | · | $-68M | $-49M | $-55M | · | $-44M | $-46M | $-41M | · | $-21M |
貸借対照表 23
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $74M | $58M | $66M | $64M | $106M | $190M | $175M | $91M | $65M | $69M | $82M | $235M | $62M | $47M | $97M | |
| Short-term Investments | $110M | $129M | $83M | $102M | $141M | $143M | $127M | $214M | $285M | $202M | $264M | $239M | $123M | $189M | · | $191M | |
| Receivables | $6M | $12M | $4M | $4M | $8M | $14M | $9M | $7M | $7M | $31M | $36M | $17M | $10M | $10M | · | $11M | |
| Prepaid Expense | $6M | $6M | $6M | $11M | $18M | $25M | $18M | $11M | $11M | $10M | $10M | $9M | $10M | $18M | · | $11M | |
| Current Assets | $176M | $221M | $151M | $182M | $232M | $287M | $343M | $406M | $443M | $355M | $422M | $381M | $412M | $304M | · | $347M | |
| PP&E (Net) | $8M | $9M | $11M | $13M | $15M | $17M | $18M | $19M | $19M | $21M | $22M | $22M | $24M | $24M | · | $24M | |
| PP&E (Gross) | · | · | $38M | · | · | · | $67M | · | · | · | $64M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $27M | · | · | · | $49M | · | · | · | $42M | · | · | · | · | · | |
| Other Non-current Assets | $1M | $1M | $495.0K | $0 | $50.0K | $85.0K | $7M | $7M | $5M | $6M | $4M | $3M | $3M | $3M | · | $2M | |
| Total Assets | $194M | $242M | $174M | $210M | $262M | $321M | $387M | $452M | $489M | $403M | $471M | $432M | $465M | $358M | · | $401M | |
| Accounts Payable | $3M | $5M | $8M | $7M | $4M | $8M | $10M | $6M | $6M | $8M | $9M | $6M | $4M | $5M | · | $12M | |
| Accrued Liabilities | $6M | $5M | $15M | $13M | $12M | $12M | $13M | $13M | $10M | $7M | $15M | $11M | $10M | $6M | · | $10M | |
| Current Liabilities | $53M | $71M | $75M | $72M | $74M | $133M | $132M | $131M | $130M | $80M | $94M | $74M | $67M | $59M | · | $58M | |
| Capital Leases | $4M | $6M | $8M | $10M | $12M | $14M | $16M | $18M | $20M | $21M | $23M | $25M | $27M | $28M | · | $31M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | · | $133.0K | |
| Total Liabilities | $298M | $309M | $306M | $297M | $294M | $347M | $343M | $341M | $337M | $305M | $321M | $319M | $310M | $173M | · | $171M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $7M | |
| Common Stock | $17.0K | $17.0K | $9.0K | $85.0K | $85.0K | $84.0K | $8.0K | $82.0K | $82.0K | $62.0K | $61.0K | $61.0K | $60.0K | $60.0K | · | $55.0K | |
| Retained Earnings | $-1.05B | $-1.02B | $-978M | $-931M | $-874M | $-863M | $-787M | $-714M | $-666M | $-618M | $-559M | $-590M | $-541M | $-503M | · | $-418M | |
| AOCI | $-58.0K | $-101.0K | $19.0K | $33.0K | $-13.0K | $-9.0K | $39.0K | $106.0K | $-163.0K | $-113.0K | $21.0K | $7.0K | $16.0K | $-107.0K | · | $-1M | |
| Stockholders' Equity | $-103M | $-67M | $-132M | $-87M | $-32M | $-26M | $45M | $111M | $152M | $98M | $150M | $112M | $155M | $185M | $217M | $230M | |
| Liabilities + Equity | $194M | $242M | $174M | $210M | $262M | $321M | $387M | $452M | $489M | $403M | $471M | $432M | $465M | $358M | · | $401M | |
| Shares Outstanding | 16,576,205 | 16,566,803 | 8,584,309 | 85,101,749 | 84,720,047 | 84,349,041 | 8,306,398 | 82,395,350 | 81,861,584 | 62,456,546 | 61,009,829 | 60,900,704 | 60,471,041 | 60,161,801 | · | 54,631,360 |
キャッシュフロー 10
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $5M | $6M | $6M | $7M | $6M | $6M | $6M | $6M | $7M | $6M | $6M | $7M | |
| Restructuring | · | $0 | $1M | $3M | $1M | $8M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-7M | · | · | · | $647.0K | · | · | · | $-14M | · | · | · | $-19M | · | · | |
| Operating Cash Flow | $-38M | $-42M | $-26M | $-38M | $-45M | $-68M | $-72M | $-65M | $9M | $-65M | $14M | $-34M | $-31M | $-61M | $-24M | $66M | |
| Investing Cash Flow | $19M | $-45M | $19M | $40M | $3M | $-16M | $87M | $147M | $-80M | $64M | $-24M | $-114M | $66M | $67M | $-38M | $-78M | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-418.0K | $103M | $-64.0K | $102.0K | $-60.0K | $66.0K | $-24.0K | $1M | $96M | $-3M | $-3M | $-6M | $138M | $9M | $12M | $30M | |
| Net Change in Cash | $-19M | $16M | $-8M | $2M | $-42M | $-84M | $16M | $84M | $26M | $-4M | $-13M | $-153M | $173M | $15M | $-50M | $18M | |
| Taxes Paid | $1.0K | $-15.0K | $64.0K | $0 | $4.0K | $7.0K | $2M | $2.0K | $15M | $10.0K | · | · | · | · | · | · |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -303.8% | -204.2% | · | -499.9% | -5.2% | -393.8% | · | -797.2% | -189.4% | -435.1% | · | -260.1% | -443.5% | -333.3% | · | -84.3% | |
| Net Margin | -391.6% | -265.0% | · | -586.6% | -18.0% | -436.6% | · | -572.6% | -186.8% | -447.5% | · | -291.2% | -370.0% | -394.9% | · | -77.5% | |
| Pretax Margin | -391.6% | -265.1% | · | -586.6% | -18.1% | · | · | -572.6% | -186.8% | -447.5% | · | -280.3% | -368.6% | -391.8% | · | -77.5% | |
| EBITDA Margin | -303.8% | -195.4% | · | -499.9% | -5.2% | -382.9% | · | -797.2% | -189.4% | -421.5% | · | -260.1% | -443.5% | -320.5% | · | -84.3% | |
| ROA | -16.9% | -13.7% | · | -17.2% | -3.1% | -21.0% | · | -11.0% | -10.1% | -15.3% | · | -11.8% | -9.1% | -15.1% | · | -5.1% | |
| ROE | 56.9% | 83.0% | · | -474.8% | -19.1% | -210.4% | · | -43.6% | -31.3% | -41.1% | · | -28.8% | -21.2% | -24.7% | · | -7.6% | |
| ROIC | 28.9% | 44.3% | · | 55.5% | 10.4% | · | · | -61.1% | -32.0% | · | · | -40.7% | -30.0% | -23.0% | · | · |
流動性と支払能力 4
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.1 | · | 2.5 | 3.1 | 2.2 | · | 3.1 | 3.4 | 4.5 | · | 5.2 | 6.1 | 5.1 | · | 5.9 | |
| Quick Ratio | 3.2 | 3.0 | · | 2.4 | 2.9 | 2.0 | · | 3.0 | 2.9 | 3.8 | · | 4.6 | 5.5 | 4.4 | · | 5.1 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
効率性 2
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | 0.0 | 0.2 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 1.4 | 1.1 | · | 1.8 | 8.5 | 0.8 | · | 0.7 | 3.0 | 0.6 | · | 1.2 | 0.2 | 1.2 | · | 2.1 |
バリュエーション（TTM） 12
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $98M | $105M | · | $99M | $115M | $65M | · | $64M | $66M | $53M | · | $65M | $76M | $72M | · | $68M | |
| Net Income TTM | $-145M | $-183M | · | $-193M | $-184M | $-231M | · | $-204M | $-194M | $-196M | · | $-157M | $-134M | $-135M | · | $-116M | |
| Market Cap | $550M | $413M | · | $74M | $60M | $55M | · | $285M | $240M | $353M | · | $211M | $281M | $278M | · | $303M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $23M | |
| P/E | -4.6 | -1.9 | · | -0.4 | -0.3 | -0.2 | · | -1.3 | -1.1 | -2.0 | · | -1.3 | -1.9 | -1.8 | · | -2.3 | |
| P/S | 5.6 | 3.9 | · | 0.7 | 0.5 | 0.8 | · | 4.4 | 3.6 | 6.7 | · | 3.2 | 3.7 | 3.9 | · | 4.5 | |
| P/B | -5.3 | -6.2 | · | -0.8 | -1.9 | -2.1 | · | 2.6 | 1.6 | 3.6 | · | 1.9 | 1.8 | 1.5 | · | 1.3 | |
| P / Tangible Book | · | · | · | · | · | · | · | 2.6 | 1.6 | 3.6 | · | 1.9 | 1.8 | 1.5 | · | 1.3 | |
| P / Cash Flow | · | -9.8 | · | · | · | -0.8 | · | · | · | -5.5 | · | · | · | -4.6 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -1.1 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.3 | |
| Earnings Yield | -22.0% | -51.5% | · | -265.5% | -314.1% | -412.3% | · | -74.6% | -89.8% | -51.1% | · | -77.0% | -51.8% | -56.5% | · | -43.8% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $102M | $62M | $154M | $68M | $62M |
| 営業利益率 % | -154.5% | -384.3% | -58.1% | -190.3% | -159.2% |
| 純利益 | $-191M | $-227M | $-107M | $-119M | $-106M |
| 希薄化後EPS | $-22.49 | $-29.40 | $-1.78 | $-2.35 | $-2.29 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 負債資本倍率 | — | — | 0.0 | 0.1 | 0.1 |
| 流動比率 | 2.0 | 2.6 | 4.5 | 5.3 | 5.2 |
| クイックレシオ | 1.9 | 2.5 | 3.9 | 4.7 | 4.2 |
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
📊
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 111 提出者 · $467.3M合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 46 (+21 前期比) | 16 (+8 前期比) | 20 (0 前期比) | 19 (+5 前期比) | +1.3M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | $43,320,887 | 1,304,846 | 9.27% | 株式数 |
| BVF INC/IL | $41,559,362 | 1,251,788 | 8.89% | 株式数 |
| Affinity Asset Advisors, LLC | $38,926,568 | 1,172,487 | 8.33% | 株式数 |
| SAMSARA BIOCAPITAL, LLC | $35,287,350 | 1,062,872 | 7.55% | 株式数 |
| Kynam Capital Management, LP | $28,968,926 | 872,558 | 6.20% | 株式数 |
| ORBIMED ADVISORS LLC | $24,698,941 | 743,944 | 5.29% | 株式数 |
| Balyasny Asset Management L.P. | $23,610,578 | 711,162 | 5.05% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $23,048,071 | 694,219 | 4.93% | 株式数 |
| EVENTIDE ASSET MANAGEMENT, LLC | $19,430,698 | 585,262 | 4.16% | 株式数 |
| Velan Capital Investment Management LP | $17,003,712 | 512,160 | 3.64% | 株式数 |
| Woodline Partners LP | $15,206,563 | 458,029 | 3.25% | 株式数 |
| ADAR1 Capital Management, LLC | $13,413,265 | 404,014 | 2.87% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $12,150,270 | 365,972 | 2.60% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $11,027,500 | 332,057 | 2.36% | 株式数 |
| STATE STREET CORP | $10,158,503 | 305,979 | 2.17% | 株式数 |
| Merck & Co., Inc. | $9,042,053 | 272,351 | 1.93% | 株式数 |
| ACUTA CAPITAL PARTNERS, LLC | $8,972,333 | 270,251 | 1.92% | 株式数 |
| AMERIPRISE FINANCIAL INC | $8,123,011 | 244,669 | 1.74% | 株式数 |
| Point72 Asset Management, L.P. | $7,895,856 | 237,827 | 1.69% | 株式数 |
| KVP Capital Advisors, LP | $7,522,290 | 226,575 | 1.61% | 株式数 |
| TWO SIGMA INVESTMENTS, LP | $6,696,042 | 201,688 | 1.43% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6,559,058 | 197,562 | 1.40% | 株式数 |
| UBS Group AG | $5,407,251 | 162,869 | 1.16% | 株式数 |
| Seven Fleet Capital Management LP | $3,794,182 | 159,118 | 0.81% | 株式数 |
| Qube Research & Technologies Ltd | $3,539,452 | 106,610 | 0.76% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $3,460,502 | 104,232 | 0.74% | 株式数 |
| CITADEL ADVISORS LLC | $3,385,205 | 101,964 | 0.72% | 株式数 |
| MACKENZIE FINANCIAL CORP | $3,146,264 | 94,767 | 0.67% | 株式数 |
| RENAISSANCE TECHNOLOGIES LLC | $2,865,957 | 86,324 | 0.61% | 株式数 |
| MARSHALL WACE, LLP | $2,448,865 | 73,761 | 0.52% | 株式数 |
| Y-Intercept (Hong Kong) Ltd | $1,855,183 | 55,879 | 0.40% | 株式数 |
| Squarepoint Ops LLC | $1,843,895 | 55,539 | 0.39% | 株式数 |
| XTX Topco Ltd | $1,732,011 | 52,169 | 0.37% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,636,826 | 49,302 | 0.35% | 株式数 |
| Sigma Planning Corp | $1,494,664 | 45,020 | 0.32% | 株式数 |
| Fisher Asset Management, LLC | $1,171,794 | 35,295 | 0.25% | 株式数 |
| Elmind Capital, LP | $1,063,628 | 32,037 | 0.23% | 株式数 |
| D. E. Shaw & Co., Inc. | $1,000,250 | 30,128 | 0.21% | 株式数 |
| GOLDMAN SACHS GROUP INC | $975,814 | 29,392 | 0.21% | 株式数 |
| Trexquant Investment LP | $917,515 | 27,636 | 0.20% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $909,116 | 27,383 | 0.19% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $863,897 | 26,021 | 0.18% | 株式数 |
| RHUMBLINE ADVISERS | $684,845 | 20,628 | 0.15% | 株式数 |
| JPMORGAN CHASE & CO | $625,079 | 18,743 | 0.13% | 株式数 |
| BlackRock, Inc. | $595,276 | 17,930 | 0.13% | 株式数 |
| SEI INVESTMENTS CO | $544,048 | 16,387 | 0.12% | 株式数 |
| Informed Momentum Co LLC | $538,902 | 16,232 | 0.12% | 株式数 |
| DEUTSCHE BANK AG\ | $516,692 | 15,563 | 0.11% | 株式数 |
| RBF Capital, LLC | $507,030 | 15,272 | 0.11% | 株式数 |
| WELLS FARGO & COMPANY/MN | $449,661 | 13,544 | 0.10% | 株式数 |
| AJU IB Investment Co., Ltd. | $435,925 | 17,500 | 0.09% | 株式数 |
| Bank of New York Mellon Corp | $434,522 | 13,088 | 0.09% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $368,520 | 11,100 | 0.08% | コールオプション |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $365,200 | 11,000 | 0.08% | プットオプション |
| MetLife Investment Management, LLC | $312,113 | 9,401 | 0.07% | 株式数 |
| Walleye Capital LLC | $308,959 | 9,306 | 0.07% | 株式数 |
| Integrated Quantitative Investments LLC | $296,775 | 8,939 | 0.06% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $279,743 | 8,426 | 0.06% | 株式数 |
| Lighthouse Investment Partners, LLC | $277,818 | 8,368 | 0.06% | 株式数 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $242,792 | 7,313 | 0.05% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $242,360 | 7,300 | 0.05% | 株式数 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $232,433 | 7,001 | 0.05% | 株式数 |
| Persistent Asset Partners Ltd | $218,091 | 6,569 | 0.05% | 株式数 |
| CITIGROUP INC | $216,995 | 6,536 | 0.05% | 株式数 |
| Verdad Advisers, LP | $212,480 | 6,400 | 0.05% | 株式数 |
| Invesco Ltd. | $211,119 | 6,359 | 0.05% | 株式数 |
| HSBC HOLDINGS PLC | $205,722 | 6,234 | 0.04% | 株式数 |
| TWO SIGMA ADVISERS, LP | $203,401 | 17,580 | 0.04% | 株式数 |
| NEW YORK STATE COMMON RETIREMENT FUND | $185,920 | 5,600 | 0.04% | 株式数 |
| MORGAN STANLEY | $181,870 | 5,478 | 0.04% | 株式数 |
| Vanguard Global Advisers, LLC | $180,774 | 5,445 | 0.04% | 株式数 |
| Police & Firemen's Retirement System of New Jersey | $156,173 | 4,704 | 0.03% | 株式数 |
| Nuveen, LLC | $131,837 | 3,971 | 0.03% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $119,520 | 3,600 | 0.03% | 株式数 |
| Nuveen Asset Management, LLC | $103,678 | 56,347 | 0.02% | 株式数 |
| BARCLAYS PLC | $84,228 | 2,537 | 0.02% | 株式数 |
| NORTHERN TRUST CORP | $83,100 | 2,503 | 0.02% | 株式数 |
| State of Wyoming | $53,718 | 1,618 | 0.01% | 株式数 |
| Legal & General Group Plc | $51,394 | 1,548 | 0.01% | 株式数 |
| Ameritas Investment Partners, Inc. | $48,074 | 1,448 | 0.01% | 株式数 |
| FMR LLC | $44,388 | 1,337 | 0.01% | 株式数 |
| Russell Investments Group, Ltd. | $42,330 | 1,275 | 0.01% | 株式数 |
| VANGUARD GROUP INC | $36,307 | 3,138 | 0.01% | 株式数 |
| Tower Research Capital LLC (TRC) | $28,751 | 866 | 0.01% | 株式数 |
| Point72 Asia (Singapore) Pte. Ltd. | $26,943 | 31,026 | 0.01% | 株式数 |
| CWM, LLC | $24,487 | 983 | 0.01% | 株式数 |
| ROYAL BANK OF CANADA | $23,000 | 687 | 0.00% | 株式数 |
| Owl Creek Wealth Partners LLC | $16,302 | 491 | 0.00% | 株式数 |
| ACADIAN ASSET MANAGEMENT LLC | $12,405 | 373,839 | 0.00% | 株式数 |
| Sterling Capital Management LLC | $9,329 | 281 | 0.00% | 株式数 |
| Quantbot Technologies LP | $6,673 | 201 | 0.00% | 株式数 |
| Physician Wealth Advisors, Inc. | $6,043 | 182 | 0.00% | 株式数 |
| MERCER GLOBAL ADVISORS INC /ADV | $3,718 | 112 | 0.00% | 株式数 |
| OSAIC HOLDINGS, INC. | $3,320 | 100 | 0.00% | 株式数 |
| PNC Financial Services Group, Inc. | $2,058 | 62 | 0.00% | 株式数 |
| Fortitude Family Office, LLC | $1,859 | 56 | 0.00% | 株式数 |
| Bogart Wealth, LLC | $1,660 | 50 | 0.00% | 株式数 |
| Parallel Advisors, LLC | $1,560 | 47 | 0.00% | 株式数 |
| NISA INVESTMENT ADVISORS, LLC | $1,461 | 44 | 0.00% | 株式数 |
| Accredited Wealth Management, LLC | $869 | 5 | 0.00% | 株式数 |
企業インサイダー 27 人のインサイダー · 14人の役員 · 14人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| William J Newell | CEO | 2023年3月3日 M | 164,816 | 0 | 0 | $0 |
| Gregory K. Chow | CFO | 2026年6月2日 M | 4,725 | 0 | 0 | $0 |
| Edward C Albini | CFO and Secretary | 2023年3月3日 M | 87,693 | 0 | 0 | $0 |
| Jane Chung | President and COO | 2023年12月1日 A | 31,698 | 0 | 0 | $0 |
| Hans-Peter Gerber | Chief Scientific Officer | 2023年9月18日 A | — | 0 | 0 | $0 |
| Brunilda Shtylla | Chief Business Officer | 2023年8月28日 S | 0 | 0 | 0 | $0 |
| Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | 2023年7月12日 M | 24,988 | 0 | 0 | $0 |
| Venkatesh Srinivasan | Chief Tech Op Officer | 2023年5月1日 A | — | 0 | 0 | $0 |
| Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | 2023年4月14日 M | 100,368 | 0 | 0 | $0 |
| Anne Elizabeth Borgman | Chief Medical Officer | 2023年3月15日 A | — | 0 | 0 | $0 |
| Anik Shabbir | Chief Technical Ops. Officer | 2023年3月3日 M | 40,827 | 0 | 0 | $0 |
| Linda A Fitzpatrick | Chief People & Comm. Officer | 2023年3月3日 M | 52,690 | 0 | 0 | $0 |
| Arturo Molina MD | Chief Medical Officer | 2022年3月5日 M | 37,736 | 0 | 0 | $0 |
| Stephen Worsley | Chief Business Officer | 2019年1月29日 A | — | 0 | 0 | $0 |
| Heidi Hunter | 取締役 | 2026年6月5日 A | — | 0 | 0 | $0 |
| Michael Dybbs | 取締役 | 2026年6月5日 A | — | 0 | 0 | $0 |
| Jon Marc Wigginton | 取締役 | 2026年6月5日 A | — | 0 | 0 | $0 |
| Sukhi Jagpal | 取締役 | 2026年6月5日 A | — | 0 | 0 | $0 |
| Joseph M Lobacki | 取締役 | 2026年6月5日 A | — | 0 | 0 | $0 |
| Daniel H Petree | 取締役 | 2026年6月5日 A | 18,601 | 0 | 0 | $0 |
| Connie Matsui | 取締役 | 2026年6月5日 A | 50,000 | 1 | 0 | $40,000 |
| James P Panek | 取締役 | 2026年6月5日 A | — | 0 | 0 | $0 |
| John Gordon Freund | 取締役 | 2023年6月8日 A | 56,327 | 0 | 0 | $0 |
| Shalini Sharp | 取締役 | 2022年6月6日 A | — | 0 | 0 | $0 |
| Daniel Janney | 取締役 | 2019年6月17日 A | 1,944,901 | 0 | 0 | $0 |
| Michael Jay Ross | 取締役 | 2018年10月1日 C | 18,248 | 0 | 0 | $0 |
| Bryan V Lawlis | 取締役 | 2018年9月26日 A | — | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 1保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| SVLSF V, LLC, SV Life Sciences Fund V, L.P., SV Life Sciences Fund V Strategic Partners, L.P., SV Life Sciences Fund V (GP), L.P., ILSF III, LLC, International Life Sciences Fund III (GP), L.P., International Life Sciences Fund III Co-Investment, L.P., International Life Sciences Fund III (LP1), L.P., International Life Sciences Fund III Strategic Partners, L.P. | 2018年10月9日 | — | 初回提出 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 15のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.43% | 3,826 SH | 2026年8月8日 | 日次 |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.25% | 28,745 SH | 2026年8月8日 | 日次 |
| IWC · iShares Trust | 0.09% | 54,216 SH | 2026年8月8日 | 日次 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 11,715 SH | 2026年8月8日 | 日次 |
| IWN · iShares Trust | 0.02% | 121,308 SH | 2026年8月8日 | 日次 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 91,894 SH | 2026年8月8日 | 日次 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 16,520 SH | 2026年8月8日 | 日次 |
| IWM · iShares Trust | 0.01% | 398,610 SH | 2026年8月8日 | 日次 |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 177,152 SH | 2026年8月8日 | 日次 |
| VHT · VANGUARD WORLD FUND | 0.01% | 47,358 SH | 2026年8月8日 | 日次 |
| IWO · iShares Trust | 0.00% | 22,665 SH | 2026年8月8日 | 日次 |
| ITOT · iShares Trust | 0.00% | 29,451 SH | 2026年8月8日 | 日次 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 501,524 SH | 2026年8月8日 | 日次 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,670 SH | 2026年8月8日 | 日次 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,330 SH | 2026年8月8日 | 日次 |